Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CytomX Therapeutics (CTMX) Change in Acquisitions & Divestments (2016 - 2025)

CytomX Therapeutics' Change in Acquisitions & Divestments history spans 11 years, with the latest figure at $30.0 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 53.85% year-over-year to $30.0 million; the TTM value through Dec 2025 reached $133.0 million, down 47.95%, while the annual FY2025 figure was $133.0 million, 47.95% down from the prior year.
  • Change in Acquisitions & Divestments reached $30.0 million in Q4 2025 per CTMX's latest filing, up from $20.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $125.0 million in Q4 2023 to a low of $10.0 million in Q3 2021.
  • Average Change in Acquisitions & Divestments over 5 years is $59.2 million, with a median of $50.5 million recorded in 2025.
  • Peak YoY movement for Change in Acquisitions & Divestments: plummeted 81.82% in 2021, then grew 25.0% in 2023.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $10.0 million in 2021, then surged by 899.8% to $100.0 million in 2022, then increased by 25.0% to $125.0 million in 2023, then plummeted by 48.0% to $65.0 million in 2024, then plummeted by 53.85% to $30.0 million in 2025.
  • Per Business Quant, the three most recent readings for CTMX's Change in Acquisitions & Divestments are $30.0 million (Q4 2025), $20.0 million (Q3 2025), and $32.5 million (Q2 2025).